Search filters

List of works by Eva M Ciruelos

A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM).

scientific article published on 16 November 2016

A prognostic model based on PAM50 and clinical variables (PAM50MET) for metastatic hormone-receptor-positive HER2-negative breast cancer

scientific article published on 22 September 2020

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial.

scientific article published on 28 March 2016

Adjuvant exemestane with ovarian suppression in premenopausal breast cancer

scientific article

Adjuvant ovarian suppression in premenopausal breast cancer

scientific article

Adjuvant therapy after preoperative treatment for breast cancer.

scientific article published on 23 June 2009

Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): ...

scientific article (publication date: December 2015)

Analysis of Paired Primary-Metastatic Hormone-Receptor Positive Breast Tumors (HRPBC) Uncovers Potential Novel Drivers of Hormonal Resistance

scientific article

Behaviour of breast cancer molecular subtypes through tumour progression

scientific article published on 01 June 2012

Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, rando

scientific article published on 28 September 2014

Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domain

scientific article published on 01 December 2006

Biweekly vinorelbine and gemcitabine: a phase I dose-finding study in patients with advanced solid tumors.

scientific article published on May 2003

CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.

scientific article published on 20 January 2015

Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination With Fulvestrant in Patients With AKT1 E17K-Mutant, ER-Positive Metastatic Breast Cancer

scientific article published on 20 April 2020

Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases

scientific article

Characterization of plasma circulating small extracellular vesicles in patients with metastatic solid tumors and newly diagnosed brain metastasis

scientific article published on 23 April 2022

Circulating epithelial tumor cells in patients with metastatic breast cancer treated with bevacizumab.

scientific article published on 23 June 2009

Combined Label-Free Quantitative Proteomics and microRNA Expression Analysis of Breast Cancer Unravel Molecular Differences with Clinical Implications

scientific article

Cost-utility analysis of nanoparticle albumin-bound paclitaxel versus paclitaxel in monotherapy in pretreated metastatic breast cancer in Spain.

scientific article published on 28 March 2013

Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: results from AVADO

scientific article published on 15 July 2011

Efficacy and safety of the administration of bevacizumab in combination with first-line chemotherapy for the treatment of advanced breast carcinoma: ATHENA MO19391 study results in Spanish patients.

scientific article published on 23 June 2009

European inter-institutional impact study of MammaPrint

scientific article published on 28 March 2014

Evaluating the role of nab-paclitaxel (Abraxane) in women with aggressive metastatic breast cancer

scientific article

Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population

scientific article published on 13 March 2020

Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.

scientific article published on 14 August 2014

Gemcitabine and capecitabine in previously anthracycline-treated metastatic breast cancer: a multicenter phase II study (SOLTI 0301 trial).

scientific article published on 25 November 2009

Getting deep in the luminal B breast cancer subtype and its ki67 cut-off value.

scientific article published on 16 November 2011

Implication of miRNA in the diagnosis and treatment of breast cancer.

scientific article published on August 2011

It is not time to stop progesterone receptor testing in breast cancer.

scientific article published in June 2005

Lapatinib plus trastuzumab in pretreated human epidermal growth factor receptor 2-positive metastatic breast cancer.

scientific article

Lobular carcinoma of the breast: outcome of 205 patients

scientific article published on 16 November 2011

Mouse p53-deficient cancer models as platforms for obtaining genomic predictors of human cancer clinical outcomes

scientific article published on 7 August 2012

Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer

scientific article published in February 2009

Nab-Paclitaxel in Metastatic Breast Cancer: Defining the Best Patient Profile.

scientific article published on 17 August 2015

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort

scientific article published on 20 March 2014

Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2+ breast cancer.

scientific article published on 23 June 2009

Palbociclib and trastuzumab in HER2-positive advanced breast cancer: Results from the phase II SOLTI-1303 PATRICIA trial

scientific article published on 16 September 2020

Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II)

article

Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer

scientific article published on 30 September 2019

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study.

scientific article

Phase I Clinical and Pharmacokinetic Study of Kahalalide F Administered Weekly as a 1-Hour Infusion to Patients with Advanced Solid Tumors

scientific article published on 01 February 2008

Phase I and pharmacokinetic study of trabectedin 3-hour infusion every three weeks in patients with advanced cancer and alteration of hepatic function

scientific article published on 10 June 2011

Phase I/II study of pilaralisib (SAR245408) in combination with trastuzumab or trastuzumab plus paclitaxel in trastuzumab-refractory HER2-positive metastatic breast cancer.

scientific article

Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)

scientific article published on 23 June 2020

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

scientific article published on 01 May 2019

Prognostic value of a high level of circulating endothelial cells in patients with HER2-recurrent or metastatic breast cancer treated with bevacizumab in combination with paclitaxel and gemcitabine as first-line therapy.

scientific article published on 16 November 2011

Radiation recall dermatitis induced by pegylated liposomal doxorubicin

scientific article published on 01 August 2003

Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia.

scientific article published on December 2006

Ribociclib-Related Stevens-Johnson Syndrome: Oncologic Awareness, Case Report, and Literature Review

scientific article published on 18 September 2019

Role of inhibitors of mammalian target of rapamycin in the treatment of luminal breast cancer.

scientific article published on September 2013

SEOM clinical guidelines for the systemic treatment of early breast cancer 2013.

scientific article published on 27 August 2013

SEOM clinical guidelines in early-stage breast cancer 2015

scientific article

SOLTI (Solid Tumor Intensification) Group experience with high-dose chemotherapy treatment for early breast carcinoma

Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cancer patients.

scientific article published on 21 December 2012

Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, [...]

scientific article

Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: results of phase IIIb BALLET trial in Spain

scientific article published on 7 November 2017

Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast Cancer ⬇️

scientific article published on March 12, 2012

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

scientific article published on 04 June 2018

The Long-HER study: clinical and molecular analysis of patients with HER2+ advanced breast cancer who become long-term survivors with trastuzumab-based therapy.

scientific article

The need for post-mastectomy radiotherapy in patients with IBC

scientific article published on 28 April 2015

The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer

scientific article published on December 2010

The present and future of gene profiling in breast cancer.

scientific article published on June 2012

The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer.

scientific article published on March 2014

Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone

scientific article

Trastuzumab in small tumours and in elderly women.

scientific article published on 06 May 2013

Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy

scientific article published on 4 January 2016

microRNA and protein expression in breast cancer formalin-fixed paraffin-embedded samples.

scientific article published on 16 November 2011

Paulina is supported by:

About Paulina

Help